Isoprostanes and hepatic fibrosis

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 43-49

  Comporti, Mario ^a   Signorini, Cinzia ^a   Arezzini, Beatrice ^a   Vecchio, Daniela ^a   Monaco, Barbara ^a   Gardi, Concetta ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Collagen synthesis; Hepatic stellate cells; Human promonocytic U937 cells; Oxidative stress; TGF

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; ISOPROSTANE DERIVATIVE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1;

CELL PROLIFERATION; CELL STRAIN U937; COLLAGEN SYNTHESIS; DNA SYNTHESIS; IN VIVO STUDY; KUPFFER CELL; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; REVIEW; STELLATE CELL;

ANIMALS; CELL PROLIFERATION; COLLAGEN; F2-ISOPROSTANES; HUMANS; ISOPROSTANES; LIVER CIRRHOSIS; OXIDATIVE STRESS;

RATTUS;

EID: 39749115727     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.011     Document Type: Review

References (31)

1. Armendariz-Borunda J., Seyer J.M., Kang A.H., and Raghow R. Regulation of TGF beta gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J. 4 (1990) 215-221
2. Benedetti A., Comporti M., and Esterbauer H. Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620 (1980) 281-296
3. 2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J. Chromatogr. B Biomed. Sci. Appl. 754 (2001) 333-343
4. Chojkier M., Houglum K., Solis-Herruzo J., and Brenner D.A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation?. J. Biol. Chem. 264 (1989) 16957-16962
5. Comporti M. Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 53 (1985) 599-623
6. Comporti M. Three models of free radical-induced cell injury. Chem. Biol. Interact. 72 (1989) 1-56
7. 2-isoprostanes are elevated in newborns and inversely correlated to gestational age. Free Radical Biol. Med. 37 (2004) 724-732
8. 2-isoprostanes stimulate collagen synthesis in activated hepatic stellate cells: a link with liver fibrosis?. Lab. Invest. 85 (2005) 1381-1391
9. 2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 99 (1999) 224-229
10. De Bleser P.J., Niki T., Rogiers V., and Geerts A. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J. Hepatol. 26 (1997) 886-893
11. Diegelmann R.F., and Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc. Natl. Acad. Sci. USA 69 (1972) 892-896
12. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11 (1991) 81-128
13. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275 (2000) 2247-2250
14. 2-isoprostane receptors on rat vascular smooth muscle cells. Am. J. Physiol. 264 (1993) C1619-C1624
15. 2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368 (1995) 225-229
16. Ignotz R.A., and Massagué J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261 (1986) 4337-4345
17. 2 alpha on retinal vessels. Am. J. Physiol. 274 (1998) R1406-R1416
18. Leonarduzzi G., Scavazza A., Biasi F., Chiarpotto E., Camandola S., Vogel S., Dargel R., and Poli G. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11 (1997) 851-857
19. Montero A., Munger K.A., Khan R.Z., Valdivielso J.M., Morrow J.D., Guasch A., Ziyadeh F.N., and Badr K.F. F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int. 58 (2000) 1963-1972
20. Morrow J.D., Harris T.M., and Roberts L.J. Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184 (1990) 1-10
21. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 (1992) 10721-10725
22. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J. Clin. Invest. 90 (1992) 502-2507
23. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure. J. Chromatogr. B Biomed. Appl. 667 (1995) 199-208
24. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., and Dianzani M.U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 194 (1993) 1044-1050
25. 2-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry. Anal. Biochem. 272 (1999) 209-215
26. Reynaud X., and Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest. Ophthalmol. Vis. Sci. 35 (1994) 3169-3177
27. Roberts L.J., and Morrow J.D. Measurement of isoprostanes to asses oxidant stress status in vivo. In: Yoshikawa T., Toyokuni S., Yamamoto Y., and Naito Y. (Eds). Free Radicals in Chemistry, Biology and Medicine (2000), OICA International, London, UK 329
28. 2-isoprostanes. J. Mass. Spectrom. 38 (2003) 1067-1074
29. 2 receptors. J. Clin. Invest. 90 (1992) 136-141
30. 2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int. 56 (1999) 471-478
31. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., and Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 40 (2004) 60-68